OMEGA THERAPEUTICS INC (OMGA)

US68217N1054 - Common Stock

2.4  -0.02 (-0.83%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
3.09M2.07M0.000.000.00
Operating Expenses
103.36M104.84M66.18M28.65M17.34M
Research and Development
65.87M76.10M47.87M21.06M11.93M
Selling, General, and Administrative Expenses
37.49M28.74M18.31M7.58M5.41M
Operating Income
-100.26M-102.77M-66.18M-28.65M-17.34M
Interest Income/Expense
2.81M220.00K-910.00K-780.00K-600.00K
Other Income/Expense
23.00K-160.00K-1.19M-30.00K-10.00K
Income Before Taxes
-97.43M-102.70M-68.28M-29.45M-17.95M
Net Income
-97.43M-102.70M-68.28M-29.45M-17.95M
EBITDA
-98.69M-101.21M-64.79M-27.50M-16.55M
 
Per Share Data
EPS Diluted Total Ops
-1.80-2.14-3.05-0.63-0.38
Non GAAP EPS
-1.81-2.14N/AN/AN/A
 
Statistics
Profit Margin
-3148.93%-4961.35%N/AN/AN/A
Operating Profit Margin
-3240.50%-4964.73%N/AN/AN/A

All data in USD

Charts